Lynch Thomas J. Jr. 4
4 · Foghorn Therapeutics Inc. · Filed Oct 31, 2022
Insider Transaction Report
Form 4
Lynch Thomas J. Jr.
Director
Transactions
- Award
Stock Options (Right to buy)
2022-10-27$8.23/sh+32,000$263,360→ 32,000 totalExercise: $8.23Exp: 2032-10-26→ Common Stock (32,000 underlying)
Footnotes (1)
- [F1]The options will vest as to one-third of the underlying shares of common stock on each of the first three anniversaries of the date of grant, subject to the recipient's continuing service on the board of directors.